AntriaBio Inc (OTCBB - OTCQB:ANTB)
| 0.99 Data as of May 22 | Today’s Change | 0.82 Today|||52-Week Range 2.50 | +842.86% Year-to-Date |
Latest ANTB News | Press Releases
No recent news for AntriaBio Inc.
Today’s Trading
| Previous close | 0.99 |
| Today’s open | n.a. |
| Day’s range | -- - -- |
| Volume | 0 |
| Average volume (3 months) | 22,514 |
| Market cap | $39.6M |
| Dividend yield | -- |
Data as of 05/22/2013
Growth & Valuation
| Earnings growth (last year) | 0.00% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --BioZone Pharmaceutic... | 0.00 | 0.00% |
| BLRXBioline RX Ltd | -0.04 | -2.40% |
| SVNTSavient Pharmaceutic... | -0.02 | -3.14% |
| IPCIIntellipharmaceutics... | +0.02 | +1.09% |
Data as of 12:48pm ET, 05/23/2013
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$49.3K |
| Net profit margin | -- |
Profile
Sector Technology Services |
Industry Internet Software/Services |
President, Chief Executive Officer & Director Nevan C. Elam |
Chief Scientific Officer Sankaram Mantripragada, PhD |
Corporate headquarters Menlo Park, California |
Forecasts

